Dingdang Health Technology Group

Dingdang Health Technology Group PEG

The PEG Ratio (Price/Earnings-to-Growth) of Dingdang Health Technology Group (9886.HK) as of Nov 3, 2026 is -0.21.

PEG

-0.21

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Dingdang Health Technology Group is 2025 -0.21 . PEG Ratio (Price/Earnings-to-Growth) of Dingdang Health Technology Group was 2024 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dingdang Health Technology Group Stock analysis

What does Dingdang Health Technology Group do? Dingdang Health Technology Group Ltd. generates revenue through its Pharmaceutical and Healthcare Business segment, which offers online direct sales, business distribution, offline smart pharmacies, express delivery services, and online medical consultation. The company also earns income from the Others segment, providing marketing services, marketplace services, and other services. Its primary customers are domestic consumers and businesses within China, leveraging its domestic market focus. The firm operates two distinct business segments to serve the pharmaceutical and healthcare needs of its target market. The company's Pharmaceutical and Healthcare Business segment focuses on delivering healthcare solutions through multiple channels, including online platforms and physical smart pharmacies, while the Others segment supports these operations with complementary services like marketing and marketplace solutions. Both segments operate exclusively within the domestic market, targeting Chinese consumers and businesses seeking pharmaceutical and healthcare services. Dingdang Health Technology Group Ltd. utilizes its two business segments to maximize revenue streams from domestic healthcare service delivery. Revenue is derived from the direct sale of pharmaceutical products, distribution services, and healthcare-related online consultations, alongside marketing and marketplace services provided to other businesses. The company’s domestic market strategy ensures that all services and products are tailored to meet the needs of Chinese consumers and businesses, with no international operations. Its business model relies on the integration of online and offline services to enhance customer experience and drive sales. Dingdang Health Technology Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dingdang Health Technology Group stock

PEG Ratio (Price/Earnings-to-Growth) of Dingdang Health Technology Group is -0.21 in 2025.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Dingdang Health Technology Group since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Dingdang Health Technology Group with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Dingdang Health Technology Group

All Key Metrics — Dingdang Health Technology Group